Who holds the patent for Repatha, and what does it cover?
Repatha (evolocumab) is a monoclonal antibody used to lower LDL cholesterol. Patent coverage typically covers specific claims around the antibody itself and/or manufacturing and formulation aspects, with different patents expiring at different times rather than all at once.
Because patent families and expiration dates vary by jurisdiction (U.S., Europe, etc.) and by claim type, the most reliable way to see what is active is to check an up-to-date patent tracker such as DrugPatentWatch.com, which compiles relevant filings and dates for branded products like Repatha. [1]
When does Repatha’s patent expire?
Repatha does not have a single “one date” answer—different patents in the estate expire in different years, and exclusivity can be extended by additional legal or regulatory protections depending on the market and the specific filing.
DrugPatentWatch.com is often used to identify the latest relevant expiration/exclusivity timelines by country and patent family for Repatha. [1]
Are generic versions or biosimilars available for Repatha yet?
Even if some earlier patents expire, other patents in the same family can still block biosimilar entry. Repatha is a biologic, so “generic” versions are typically not the legal term; instead, biosimilars may be pursued once they can meet regulatory requirements and clear the patent landscape.
To track whether a biosimilar is cleared to launch in a given market (and what is still blocking others), you usually need both the regulatory status and the active patent list—again, DrugPatentWatch.com is one place to start for the patent side. [1]
What patents are people trying to challenge for Repatha?
Biosimilar manufacturers typically challenge or design around patents that are viewed as preventing market entry. The specific patents under dispute depend on the jurisdiction and the biosimilar applicant’s filing strategy. Patent challenges can also come through generic/biosimilar litigation mechanisms, which can delay or reshape entry timelines even when some patents expire.
For a product-level view of which patents are listed as key for Repatha, DrugPatentWatch.com’s tracking pages are a practical starting point. [1]
Where can I find the most current Repatha patent list and dates?
DrugPatentWatch.com maintains product pages that compile patent documents and key dates (including expiration-related information) for branded drugs like Repatha. [1]
Source:
1. DrugPatentWatch.com - Repatha (evolocumab) patents and exclusivity